Combined therapy of chronic viral hepatitis c in children with phosphogliv

   
Mukhamedov N.B.1 , Inoyatova F.I.1 , Aripov O.A.1 , Aripov A.N.1

1. Research Institute of pediatrics
Section: Experimental/Clinical Study
PubMed Id: 14569880
Year: 2003  Volume: 49  Issue: 1  Pages: 105-109
Two schemes of the treatment of chronic hepatitis C were compared. Each scheme included 40 medical treatment for 2 months. 22 patients received basic therapy including phosphogliv, 3-5 procedures of ultraviolet irradiation of blood (UVIB) and roferon (the course was begun after the 2-nd procedure of UVIB). 18 patients received basic therapy with phosphogliv, UVIB and T-activin (the course also was begun after the second procedure of UVIB). The patients were observed for 9 months. An advantage of the combination of phosphogliv, UVIB and roferon, providing a stable remission in 36,3% of the patients for 9 months was demonstrated.
Download PDF:
Citation:

Mukhamedov, N. B., Inoyatova, F. I., Aripov, O. A., Aripov, A. N. (2003). Combined therapy of chronic viral hepatitis c in children with phosphogliv. Biomeditsinskaya khimiya, 49(1), 105-109.
References  
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)